Tag - medicine

 
 

MEDICINE

Japan Times
COMMENTARY / World
Sep 2, 2021
COVID-19 vaccines may become a viable business. That’s a problem.
Inoculations have been distributed to almost every person on the planet. But, traditionally, they been unprofitable for the pharmaceutical industry.
Japan Times
JAPAN
Sep 1, 2021
Japan finds another Moderna vial suspected to contain foreign substance
Kanagawa Prefecture said it had put the suspected lot of the firm's COVID-19 vaccine on hold after about 3,790 people had already received shots from the same lot.
Japan Times
JAPAN / Explainer
Aug 30, 2021
Foreign substances in Japan's Moderna shots: Here's what you need to know
Other possibly contaminated batches have been reported in recent days, but experts say health risks are low.
Japan Times
COMMENTARY / World
Aug 29, 2021
New treatment emerges amid COVID-19 vaccine efficacy concerns
With studies showing COVID-19 vaccine efficacy declining faster than expected, boosters aren't the only option, and in some cases they may not even be the best.
Japan Times
JAPAN
Aug 28, 2021
Staff shortages and delta threaten Japan's highly successful record of treating severe COVID-19 cases
As severe cases surge, hospitals have been hit by a lack of staff as well as a dearth of physicians capable of using special equipment such as ECMO machines.
Japan Times
JAPAN
Aug 27, 2021
Japan to use ¥1.4 trillion in reserve funds for COVID-19 measures
u00a5841.5 billion will be used for more vaccines, while around u00a5235.2 billion was earmarked for coronavirus-related treatments.
Japan Times
WORLD / Science & Health
Aug 27, 2021
Blood clot risk much higher for COVID-19 patients than from vaccines, study finds
The study followed 29 million people who received doses of either the AstraZeneca or Pfizer vaccine between December 2020 and April and about 1.7 million COVID-19 patients.
Japan Times
JAPAN / FOCUS
Aug 24, 2021
Japan turns to antibody cocktails as 'new weapon' in fight against pandemic
The government has widened the use of the drug Ronapreve, but some doctors say it needs to go further and make it available to patients isolating at home too.
Japan Times
COMMENTARY / World
Aug 19, 2021
Australia's 'authoritarian' COVID-19 response
Australia, once the envy of the world for its pandemic management, is now being criticized by some over the authoritarian measures it is using to crush COVID-19.
Japan Times
COMMENTARY / World
Aug 19, 2021
Hong Kong's COVID-19 policies are borderline reckless
The government's inability to adapt while failing to put in place policies that ensure long-term safety are standing in the way of keeping the public's trust.
Japan Times
WORLD / FOCUS
Aug 17, 2021
Antibody cocktails to treat COVID-19 take off as delta surges in U.S.
As the delta variant surges, one drug cocktail is rapidly becoming a more common, even routine medical response to positive coronavirus tests in high-risk patients in the United States.
Japan Times
COMMENTARY / World
Aug 12, 2021
Can Moderna buy its way into the $200 billion club?
Moderna's COVID-19 windfall sees its market valuation surged by more than $100 billion since May.
Japan Times
JAPAN
Aug 11, 2021
Japan backs 'revolutionary' COVID-19 drug Ronapreve to help tame crisis
The antibody cocktail, intended for mildly and moderately ill patients, could in the near future be used to treat those quarantining at home, helping to ease the strain on hospitals.
Japan Times
COMMENTARY / World
Aug 11, 2021
Not vaccinated? Here’s how you could kill someone’s father
Misinformation, or even mere scientific confusion, can cause a lot of trouble when it appears to come out of the Centers for Disease Control.
Japan Times
ASIA PACIFIC / Science & Health
Aug 9, 2021
China’s COVID-19 strategy risks leaving it isolated for years
China is tethering itself to eliminating the virus over the long term — an approach that risks leaving the world's second-biggest economy isolated for years to come.
Japan Times
WORLD
Aug 9, 2021
Beyond delta, scientists are watching new coronavirus variants
Scientists remain focused on delta, now the dominant variant rising rapidly around the world, but they are tracking others to see what may one day take its place.
Japan Times
JAPAN
Aug 6, 2021
Japan drugmaker Shionogi to seek approval for oral COVID-19 drug
Designed to prevent moderate COVID-19 symptoms from worsening, the drug could facilitate at-home treatment and ease the strain on hospitals.
Japan Times
COMMENTARY / World
Aug 5, 2021
Why vaccination should be compulsory
Laws requiring people to be vaccinated may be restricting one kind of freedom, but they are doing so in order to protect the freedom of others to go about their business safely.
Japan Times
BUSINESS / Companies
Aug 4, 2021
SoftBank built a $5 billion stake in pharma giant Roche
Roche's diagnostics unit reacted swiftly to the pandemic, and now sales are boosted by its COVID-19 testing business.
Japan Times
COMMENTARY / World
Aug 2, 2021
More shots alone won’t win the global war on variants
The delta COVID-19 variant is tipping the pandemic into a frightening new stage and vaccination efforts are unable to keep up.

Longform

Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
The neurological disorder that 'kills culture'